Share General Information
Icatibant acetate is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults. HAE is a rare, potentially life-threatening disease characterized by intermittent and unpredictable attacks of sudden swelling involving various organs.
About the API
-
Japan DMF
-
Korea DMF
-
US DMF
The information detailed herein, including that with regard to active pharmaceutical ingredients , their use in treatments and possible mechanism(s) of action, was all obtained from public sources.
For more information on our services and products – including product suitability, intended uses and current availability – please contact Teva api Customer Service. CAS Registry Number is a Registered Trademark of the American Chemical Society. This webpage and any reference to the above product is to be read within the meaning and terms of the Legal Notes.
